News Nokia exec says no future for digital health unit - report Memo adds to speculation Nokia could close digital health business
News Immunotherapy arms race latest: Merck buys Viralytics for $3... Big pharma pays 160% premium for Australian biotech
News Lilly axes trial of Hanmi's arthritis drug Lilly may decide to develop drug in other indications
News AZ signs kidney drug deal with Ionis for up to $330m Deal is result of six-year collaboration with AZ
News Roche to buy health records firm Flatiron for $1.9bn Flatiron has backers including Google parent Alphabet
News Concerns mount over Biogen Alzheimer's drug FDA announces guidance to encourage development of new drugs
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
